(VIANEWS) – INPOST (INPST.AS), WDP (WDP.BR), DASSAULT SYSTEMES (DSY.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. INPOST (INPST.AS)
21.7% sales growth and 72.91% return on equity
InPost S.A., together with its subsidiaries, operates as an out-of-home e-commerce enablement platform providing parcel locker services in Europe. It operates through four segments: APM (Automated Parcel Machines), To-Door, Mondial Relay, and International Other. The APM segment focuses on the delivery of parcels to APM. The To-Door segment delivers parcels using door-to-door couriers. The Mondial Relay segment delivers parcels to APM; and operates pick-up drop-off (PUDO) points in France, Spain, Belgium, the Netherlands, Luxembourg, and Portugal. The International Other segment delivers parcels to APM and PUDO points in the United Kingdom and Italy. The company also provides fulfilment services; marketing and IT services; InPost Pay services; and platform for fast-moving consumer goods products through InPost Fresh app. InPost S.A. was founded in 1999 and is headquartered in Luxembourg, Luxembourg.
Earnings Per Share
As for profitability, INPOST has a trailing twelve months EPS of €0.37.
PE Ratio
INPOST has a trailing twelve months price to earnings ratio of 44.49. Meaning, the purchaser of the share is investing €44.49 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72.91%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.7%, now sitting on 9.27B for the twelve trailing months.
More news about INPOST.
2. WDP (WDP.BR)
12.5% sales growth and 4.89% return on equity
WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €0.97.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 25.4. Meaning, the purchaser of the share is investing €25.4 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.89%.
Sales Growth
WDP’s sales growth is 14.5% for the present quarter and 12.5% for the next.
Yearly Top and Bottom Value
WDP’s stock is valued at €24.64 at 17:20 EST, way below its 52-week high of €28.94 and way above its 52-week low of €22.16.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 4.53%.
Moving Average
WDP’s worth is under its 50-day moving average of €25.32 and under its 200-day moving average of €26.01.
More news about WDP.
3. DASSAULT SYSTEMES (DSY.PA)
6.9% sales growth and 14.34% return on equity
Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS provides easy-to-use 2D and 3D product development solutions accessible to any business; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure, and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. The company distributes its products through direct and indirect sales channels. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; infrastructure, energy, and materials; home and lifestyle; architecture, engineering, and construction; cities, and public services; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.79.
PE Ratio
DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 51.95. Meaning, the purchaser of the share is investing €51.95 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 27, 2024, the estimated forward annual dividend rate is 0.23 and the estimated forward annual dividend yield is 0.67%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 7.1% and 7.1%, respectively.
More news about DASSAULT SYSTEMES.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.72. Meaning, the purchaser of the share is investing kr17.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 6, 2024, the estimated forward annual dividend rate is 1.75 and the estimated forward annual dividend yield is 8.25%.
More news about VISTIN PHARMA.
5. IMCD (IMCD.AS)
5.4% sales growth and 16.47% return on equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, film formers, humectants, waxes, conditioners, hair styling polymers, solvent, solubilizers, pigments, pearls, powders and colorants, opacifiers, pearlizers, preservatives, antioxidants, fragrances, and essential oils. In addition, the company provides functional fillers, pigments, resins, and specialty solvents; taste, texture, nutrition, and function; and abrasives, acids, alkalines, anti-soil redeposition and foam control systems, bio-actives, biocides, bittering and bleaching agents, builders, capsules, chelating agents, concentrates/ready-to-use, corrosion and dye transfer inhibitors, disintegrants, dispersants, emulsifiers, enzymes, fluorinated polymers, oleo chemicals, optical brighteners, perfumes, dyes, phosphates, plasticisers, proteins, rheology modifiers and thickeners, silicones, solvents/diluents, TAED, UV-filters, and waxes. Further, it offers base oils; lubricants addictive; lubricants finished fluids; fuel additives; solvents, degreasers, and fuel compounds; and upstream, midstream, and downstream oil, gas, and energy. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €4.93.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 28.45. Meaning, the purchaser of the share is investing €28.45 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.47%.
Volume
Today’s last reported volume for IMCD is 10478 which is 88.29% below its average volume of 89487.
Yearly Top and Bottom Value
IMCD’s stock is valued at €140.25 at 17:20 EST, way below its 52-week high of €169.05 and way higher than its 52-week low of €109.05.
Sales Growth
IMCD’s sales growth is negative 1.6% for the present quarter and 5.4% for the next.
More news about IMCD.
